Joshua Mali, MD, offers up his predictions for ophthalmology in 2024.
Ophthalmology Times: January 2024
Ophthalmologist shares pearls from recent roundtable discussion on topic.
Physicians note the impact of prism lenses can be life-changing for patients.
Genetic testing is proving to be an evolving technology for ophthalmologists.
Two retina specialists participated in an Ophthalmology Times case-based roundtable discussion and shared their experiences using the anti-VEGF biosimilars, ranibizumab-eqrn and ranibizumab-nuna to manage retinal diseases.
Siloam Vision and Orbis team up to develop infrastructure to save the vision of premature infants.
Patients are encouraged to choose the optimal technology for their particular situation.
Advances enhance clinical decision-making in screening cases at risk of iatrogenic ectasia.
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Glaukos receives FDA approval for Epioxa topical therapy for keratoconus
2
Dompé's NAION program selected for FDA Commissioner’s National Priority Voucher Program
3
Q&A: Insights from Rajesh K. Rajpal, MD, on an incision-free keratoconus therapy
4
Aurion Biotech releases positive 12-month results from phase 1/2 CLARA trial
5
.png "Optometry Times"){kind=logo}
